Clinical Trial Update: A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003) [Phase 1]

View source ↗

Summary

MK-7602-003 has completed a Phase 1 trial evaluating the safety and potential antimalarial activity of MK-7602 in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• MK-7602

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Malaria | Phase 1 | Status: COMPLETED